Showing results (21-30 of 617) with videos related to
Sort By:
Pageof 62
Expert Opinion on Pharmacotherapy|August 5, 2021
Current and emerging gluconeogenesis inhibitors for the treatment of Type 2 diabetesMarc S RendellExpert Review of Endocrinology & Metabolism|November 1, 2018
Sotagliflozin: a combined SGLT1/SGLT2 inhibitor to treat diabetesMarc S RendellDrug Design, Development and Therapy|March 19, 2019
The journey from gene knockout to clinical medicine: telotristat and sotagliflozinMarc S RendellThe Mount Sinai Journal of Medicine, New York|February 8, 2002
The Mount Sinai Hospital's role in the development of anesthesia safety standardsLeslie Rendell-BakerExpert Opinion on Drug Safety|July 6, 2017
The safety of albiglutide for the treatment of type 2 diabetesMarc S RendellExpert Opinion on Pharmacotherapy|December 8, 2017
Efficacy and safety of sotagliflozin in treating diabetes type 1Marc S RendellAnesthesia and Analgesia|January 1, 1976
Some gas machine hazards and their eliminationL Rendell-BakerExpert Opinion on Biological Therapy|September 29, 2016
Albiglutide: a unique GLP-1 receptor agonistMarc S RendellAustralian Veterinary Journal|November 25, 2010
Anthelmintic resistance in cattle nematodes on 13 south-west Victorian propertiesD K RendellExpert Review of Endocrinology & Metabolism|August 1, 2018
Albiglutide for the management of type 2 diabetesMarc S RendellPageof 62